SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Medscape Inc - ( Nasdaq - MSCP ) -- Ignore unavailable to you. Want to Upgrade?


To: $Mogul who wrote (3)7/26/1999 7:57:00 PM
From: Mohan Marette  Read Replies (2) | Respond to of 62
 
7/26/99 Price range set to $11-$13 & number of shares to 5,400,000.



To: $Mogul who wrote (3)8/3/1999 12:14:00 AM
From: Money Machine  Respond to of 62
 
I just read the preliminary prospectus. I like it! I work for a healthcare information systems company, and I like Medscape's overall strategy and the user groups they target. Having "physician eyeballs" is crucial, and if they can establish themselves among physicians then Medscape should do very well in terms of raking in sponsorships and ad revenue. I liked their having 210,000 physician-members, the CBS stake, the fact that they've been up and going since 1996, their well-rounded content, a reputable editor-in-chief, and what I consider a good reason for existence.



To: $Mogul who wrote (3)8/30/1999 5:06:00 PM
From: jlivea  Read Replies (1) | Respond to of 62
 
Mogul, How would you compare MSCP against HGAT and AMDR. All three are scheduled to hit the market in the week past labor day.

A response will be appreciated.

Thanks